'It's Totally Irresponsible': Canadian Ethicist Slams Rogue Russian's Plan to Edit Human Embryos
By Gemma Buck,
National Post
| 07. 08. 2019
Canadian bioethicists and genetics experts are speaking out against Denis Rebrikov, the Russian molecular biologist who plans — in defiance of international scientific norms — to alter human embryos using CRISPR gene-editing technology to allow prospective parents with genetic deafness to conceive a child who can hear.
“We are putting ourselves on the path to changing the human evolutionary story. This is not up to one scientist. It’s not up to a group of scientists or a group of political elites. It’s up to all of us,” said Françoise Baylis, a professor of philosophy and bioethics at Dalhousie University who serves on a World Health Organization committee that is developing global standards and oversight for editing of the human genome.
The ethical implications of this kind of rogue science are wide-ranging and nuanced, Baylis explained. But the obvious ones are dire: Making genetic changes to eggs, sperm, or early embryos, collectively called the human germline, affects not only the eventual person these cells may become, but also their offspring.Though there is a “spectrum” of views among scientists and ethicists about...
Related Articles
By Aisha Down, The Guardian | 11.10.2025
It has been an excellent year for neurotech, if you ignore the people funding it. In August, a tiny brain implant successfully decoded the inner speech of paralysis patients. In October, an eye implant restored sight to patients who had...
By Jessica Hamzelou, MIT Technology Review | 11.07.2025
This week, we heard that Tom Brady had his dog cloned. The former quarterback revealed that his Junie is actually a clone of Lua, a pit bull mix that died in 2023.
Brady’s announcement follows those of celebrities like Paris...
By Heidi Ledford, Nature | 10.31.2025
Late last year, dozens of researchers spanning thousands of miles banded together in a race to save one baby boy’s life. The result was a world first: a cutting-edge gene-editing therapy fashioned for a single person, and produced in...
By Lauran Neergaard, AP News | 11.03.2025
WASHINGTON (AP) — The first clinical trial is getting underway to see if transplanting pig kidneys into people might really save lives.
United Therapeutics, a producer of gene-edited pig kidneys, announced Monday that the study’s initial transplant was performed successfully...